WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Student fatally shot, suspect detained at Georgia's Kennesaw State University
Explore the delights of Chengdu People's Park with Rongbao
China makes headway in building international commercial arbitration centers
Revealed: Brit tourist, 19, subjected to sex attack in Majorca 'was gang
Israeli troops withdrawn from Gaza to prepare Rafah operation: defense minister
Eurozone inflation further cools in March
China releases ecological protection compensation regulations
Investigators return to Long Island home of Gilgo Beach serial killing suspect
Russia says proof show link between Moscow attack terrorists, Ukraine
'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
Cao Maoyuan: Chinese athlete shines as first gold medalist at Chengdu Universiade